65--Xellia Pharmaceuticals 09/15/2019 - 09/14/2024
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) has awarded Mesoblast, Inc. a contract for Drugs And Biologicals (PSC 6505) under Solicitation Number M5-Q50A-03-R8. The contract is effective from February 15, 2026, to February 14, 2031.
Contract Details
This is an Award Notice for a contract issued by the VA's National Acquisition Center (NAC FEDERAL SUPPLY SCHEDULE (36F797)) in Hines, IL. The award is associated with Solicitation Number M5-Q50A-03-R8, which is a Worldwide Federal Supply Schedule (FSS) Contract for Drugs, Pharmaceuticals & Hematology Related Products (FSC Group 65, Part I, Section B). The stated award amount is $0.00, which is typical for FSS contracts where the actual value is determined by subsequent task orders. The NAICS Code associated with the solicitation is 325412.
Solicitation Context & Amendments
The underlying solicitation (M5-Q50A-03-R8) is a standing solicitation with no closing date for offers, allowing for continuous awards. Recent amendments to this solicitation have introduced several key updates that may impact future offers or contract management:
- Amendment 0010 (April 2026): Incorporated new clauses for Option to Extend the Term of the FSS Contract (GSAM/GSAR 552.238-116) and clarified the Consideration of Offers Under Standing Solicitation (A-FSS-11), confirming contracts are typically for 5 years with extension options.
- Amendment 0009 (December 2025/April 2026): Updated Economic Price Adjustment clauses (GSAM 552.238-120), revised Responsibility Evaluation requirements for new VA FSS offers (October 2025), and updated the Signature Authority form (August 2025).
- Amendment 0008 (March 2026): Updated various FAR clauses (e.g., 52.203-17, 52.212-3, 52.212-5) and added a new Responsibility Evaluation Document.
- Amendment 0006 (March/April 2026): Reduced the grace period for Industrial Funding Fee (IFF) and Sales Reporting from 60 days to 30 days after the reporting quarter.
- Amendment 0004 (March 2026): Revised electronic offer submission procedures, emphasizing digital signatures and specific file formats, and updated various FAR, GSAR, and VAAR clauses.
Set-Aside
No specific set-aside is indicated for this individual award. The underlying solicitation is open to all responsible offerors, with various small business set-aside clauses incorporated for potential future orders.
Contact Information
For further information, contact the FSS Help Desk at FSS.Help@va.gov or (708) 786-7737.